108 related articles for article (PubMed ID: 23140590)
41. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer.
Piscaglia F; Corradi F; Mancini M; Giangregorio F; Tamberi S; Ugolini G; Cola B; Bazzocchi A; Righini R; Pini P; Fornari F; Bolondi L
BMC Cancer; 2007 Sep; 7():171. PubMed ID: 17767722
[TBL] [Abstract][Full Text] [Related]
42. Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis.
Rahbin N; Siösteen AK; Elvin A; Blomqvist L; Hagen K; Hultcrantz R; Aleman S
Acta Radiol; 2008 Apr; 49(3):251-7. PubMed ID: 18365808
[TBL] [Abstract][Full Text] [Related]
43. Contrast-enhanced ultrasonography in the follow-up of patients with hepatic metastases from breast carcinoma.
Della Vigna P; Cernigliaro F; Monfardini L; Gandini S; Bellomi M
Radiol Med; 2007 Feb; 112(1):47-55. PubMed ID: 17310292
[TBL] [Abstract][Full Text] [Related]
44. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study.
Larsen LP; Rosenkilde M; Christensen H; Bang N; Bolvig L; Christiansen T; Laurberg S
Eur J Radiol; 2007 May; 62(2):302-7. PubMed ID: 17194561
[TBL] [Abstract][Full Text] [Related]
45. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
Quaia E
Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
[TBL] [Abstract][Full Text] [Related]
46. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
47. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
[TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
49. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.
Sirli R; Sporea I; Popescu A; Dănilă M; Martie A; Bota S; Jurchis A; Sendroiu M
Med Ultrason; 2011 Jun; 13(2):95-101. PubMed ID: 21655534
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma presenting as a wandering abdominal lump with atypical CEUS.
Xu HS; Li SY; Liang X; Shou JD; Xu K; He YT
Ultraschall Med; 2013 Aug; 34(4):388-90. PubMed ID: 23929380
[No Abstract] [Full Text] [Related]
51. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
52. Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation?
Meloni MF; Andreano A; Franza E; Passamonti M; Lazzaroni S
Eur J Radiol; 2012 Aug; 81(8):e897-902. PubMed ID: 22658846
[TBL] [Abstract][Full Text] [Related]
53. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance.
Beyer-Enke SA; Hocke M; Ignee A; Braden B; Dietrich CF
JOP; 2010 Sep; 11(5):427-33. PubMed ID: 20818109
[TBL] [Abstract][Full Text] [Related]
54. [Comments on the EFSUMB non-liver Guidelines 2011].
Dietrich CF; Schreiber-Dietrich D; Hocke M
Praxis (Bern 1994); 2012 Sep; 101(18):1175-81. PubMed ID: 22945818
[TBL] [Abstract][Full Text] [Related]
55. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
[TBL] [Abstract][Full Text] [Related]
56. Characterization of focal liver lesions using contrast enhanced ultrasound as a first line method: a large monocentric experience.
Sporea I; Martie A; Bota S; Sirli R; Popescu A; Dănila M
J Gastrointestin Liver Dis; 2014 Mar; 23(1):57-63. PubMed ID: 24689098
[TBL] [Abstract][Full Text] [Related]
57. Treatment response evaluation with three-dimensional contrast-enhanced ultrasound for liver cancer after local therapies.
Xu HX; Lu MD; Xie XH; Xie XY; Kuang M; Xu ZF; Liu GJ; Wang Z; Chen LD; Lin MX
Eur J Radiol; 2010 Oct; 76(1):81-8. PubMed ID: 19500929
[TBL] [Abstract][Full Text] [Related]
58. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial.
Wang WP; Wu Y; Luo Y; Li R; Zhou XD; Zhang J; Qian CW; Tan XY; Xu QH; Wang Y; Yuan JJ
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):370-6. PubMed ID: 19666405
[TBL] [Abstract][Full Text] [Related]
59. Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Laghi F; Catalano O; Maresca M; Sandomenico F; Siani A
Ultraschall Med; 2010 Jun; 31(3):283-8. PubMed ID: 20517816
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
